Nothing Special   »   [go: up one dir, main page]

ZA201204619B - Pharmaceutical composition comprising vitamin d analogue and cosolventsurfactant mixture - Google Patents

Pharmaceutical composition comprising vitamin d analogue and cosolventsurfactant mixture

Info

Publication number
ZA201204619B
ZA201204619B ZA2012/04619A ZA201204619A ZA201204619B ZA 201204619 B ZA201204619 B ZA 201204619B ZA 2012/04619 A ZA2012/04619 A ZA 2012/04619A ZA 201204619 A ZA201204619 A ZA 201204619A ZA 201204619 B ZA201204619 B ZA 201204619B
Authority
ZA
South Africa
Prior art keywords
cosolventsurfactant
analogue
vitamin
mixture
pharmaceutical composition
Prior art date
Application number
ZA2012/04619A
Inventor
Karsten Petersson
Original Assignee
Leo Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharma As filed Critical Leo Pharma As
Publication of ZA201204619B publication Critical patent/ZA201204619B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/113—Multiple emulsions, e.g. oil-in-water-in-oil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA2012/04619A 2009-12-22 2012-06-21 Pharmaceutical composition comprising vitamin d analogue and cosolventsurfactant mixture ZA201204619B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/DK2009/000266 WO2011076206A1 (en) 2009-12-22 2009-12-22 Pharmaceutical composition comprising vitamin d analogue and cosolvent-surfactant mixture

Publications (1)

Publication Number Publication Date
ZA201204619B true ZA201204619B (en) 2013-09-25

Family

ID=44194970

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2012/04619A ZA201204619B (en) 2009-12-22 2012-06-21 Pharmaceutical composition comprising vitamin d analogue and cosolventsurfactant mixture

Country Status (13)

Country Link
EP (1) EP2515912A4 (en)
JP (1) JP5548275B2 (en)
CN (1) CN102770143B (en)
AU (1) AU2009357263B2 (en)
BR (1) BR112012015447A2 (en)
CA (1) CA2785249A1 (en)
HK (1) HK1177695A1 (en)
IL (1) IL220513A (en)
MX (1) MX2012007227A (en)
NZ (1) NZ601002A (en)
RU (1) RU2500387C1 (en)
WO (1) WO2011076206A1 (en)
ZA (1) ZA201204619B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107643354B (en) * 2016-07-22 2022-02-01 重庆华邦胜凯制药有限公司 Separation and determination method of calcipotriol starting material A and related impurities
CN106265485A (en) * 2016-08-22 2017-01-04 江苏知原药业有限公司 A kind of calcipotriol compositions of improved stability
CN106265511A (en) * 2016-08-22 2017-01-04 江苏知原药业有限公司 A kind of calcipotriol betamethasone self-micro emulsion formulation of excellent performance
CN106344589B (en) * 2016-11-10 2019-11-26 江苏知原药业有限公司 A kind of Calcipotriol betamethasone composition of improved stability
CN108904445A (en) * 2018-08-06 2018-11-30 江苏知原药业有限公司 Its salts nano suspending liquid
US20230225970A1 (en) * 2020-08-26 2023-07-20 Canadian Nano Pharmaceutical Technology Inc. Nano-Emulsion Based Compositions, Methods for Their Preparation and Their Use in Delivery of Active Ingredients
CN115350151B (en) * 2022-09-29 2023-09-12 湖北欣泽霏药业有限公司 High-stability alfacalcidol liquid oral preparation and preparation method thereof
CN116473985A (en) * 2023-03-29 2023-07-25 暨南大学 Polyene antifungal pharmaceutical composition and application thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763426A (en) * 1993-01-15 1998-06-09 Leo Pharmaceutical Products Ltd. Crystalline form of a vitamin D analogue
JP3340310B2 (en) * 1996-03-28 2002-11-05 株式会社資生堂 Composite emulsion and method for producing the same
CA2312060A1 (en) * 1997-12-09 1999-06-17 Chugai Seiyaku Kabushiki Kaisha Lotions containing vitamin d3 derivatives
EP1040832A4 (en) * 1997-12-09 2001-09-12 Chugai Pharmaceutical Co Ltd Creams containing vitamin d 3 derivatives
US5990100A (en) * 1998-03-24 1999-11-23 Panda Pharmaceuticals, L.L.C. Composition and method for treatment of psoriasis
US8263580B2 (en) * 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
JP2002543062A (en) * 1999-04-23 2002-12-17 レオ・ファーマ・アクティーゼルスカブ Vitamin D analogs and their pharmaceutical use
JP2001025359A (en) * 1999-07-15 2001-01-30 Mitsubishi-Kagaku Foods Corp O/w/o type emulsion composition and its production
MX2007015672A (en) * 2005-06-10 2008-02-20 Galderma Sa Controlled release of a drug through skin on the basis of a topical composition comprising a drug, a film-forming silicone and at least one volatile solvent.
US20060286054A1 (en) * 2005-06-15 2006-12-21 Apollo Pharmaceutical, Inc. Pharmaceutical compositions for the treatment of psoriasis
FR2893847B1 (en) * 2005-11-30 2010-10-29 Galderma Sa SPRAY COMPOSITION COMPRISING VITAMIN D DERIVATIVE AND OILY PHASE
JP4913487B2 (en) * 2006-07-07 2012-04-11 ポーラ化成工業株式会社 Cosmetics characterized by a feeling of use
FR2909284B1 (en) * 2006-11-30 2012-09-21 Galderma Sa NOVEL VASELIN-FREE OINTMENTAL COMPOSITIONS COMPRISING VITAMIN D DERIVATIVE AND POSSIBLY STEROID ANTI-INFLAMMATORY
FR2911781B1 (en) * 2007-01-26 2009-03-20 Fabre Pierre Dermo Cosmetique DERMATOLOGICAL EMULSION AND PREPARATION METHOD
US10265265B2 (en) * 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
EP1970049A1 (en) * 2007-03-15 2008-09-17 Drug Delivery Solutions Limited Polyaphron topical composition with vitamin D and corticosteroid

Also Published As

Publication number Publication date
AU2009357263A1 (en) 2012-07-19
CN102770143A (en) 2012-11-07
MX2012007227A (en) 2012-07-30
WO2011076206A1 (en) 2011-06-30
HK1177695A1 (en) 2013-08-30
CN102770143B (en) 2014-11-05
JP5548275B2 (en) 2014-07-16
NZ601002A (en) 2014-09-26
EP2515912A1 (en) 2012-10-31
EP2515912A4 (en) 2013-12-25
IL220513A (en) 2016-05-31
CA2785249A1 (en) 2011-06-30
BR112012015447A2 (en) 2016-03-15
RU2500387C1 (en) 2013-12-10
JP2013515017A (en) 2013-05-02
IL220513A0 (en) 2012-08-30
AU2009357263B2 (en) 2015-04-09

Similar Documents

Publication Publication Date Title
IL275854A (en) Pharmaceutical composition and administration thereof
HK1250313A1 (en) Stable pharmaceutical composition and methods of using same
IL253870B (en) Certain amino-pyrimidines and pharmaceutical compositions comprising them
IL247260A0 (en) A pharmaceutical spray composition comprising a vitamin d analogue and a corticosteroid
IL217912A (en) 5-amino-1- benzimidazole-pyrazole derivatives and pharmaceutical compositions comprising them
ZA201200722B (en) Pharmaceutical composition and administrations thereof
IL215497A0 (en) Oxadiazile derivatives and pharmaceutical compositions containing them
ZA201100605B (en) Micronised progesterone pharmaceutical composition and uses thereof
HK1177695A1 (en) Pharmaceutical composition comprising vitamin d analogue and cosolvent- surfactant mixture d-
PT2474522E (en) Agomelatine and pharmaceutical compositions thereof
IL206594A (en) Azinone-tetrahydropyridoindole derivatives and pharmaceutical compositions comprising thereof
ZA201200079B (en) Pharmaceutical compositions and solid forms
HK1177696A1 (en) Pharmaceutical composition comprising solvent mixture and a vitamin derivative or analogue
GB0902648D0 (en) Pharmaceutical compounds and compositions
IL219018A (en) Pharmaceutical compositions of radezolid and uses thereof
GB0908317D0 (en) Pharmaceutical compounds and compositions
GB0919055D0 (en) Pharmaceutical compounds and compositions
GB0902651D0 (en) Pharmaceutical compounds and compositions
GB0903945D0 (en) Pharmaceutical compounds and compositions
GB0908069D0 (en) Pharmaceutical compounds and compositions